Diagnostic value of CEACAM6 and HE4 in pleural fluid for malignant pleural effusion

Pleural CEACAM6 and HE4 are promising biomarkers for distinguishing MPE from BPE. Their combination improves diagnostic accuracy, offering a valuable tool for MPE diagnosis, especially in challenging cases with cytology-negative pleural effusion.

Authors

Institutions

Publication Details

Journal
Annals of Medicine
Published
2025-04-15
DOI
https://doi.org/10.1080/07853890.2025.2489748
Citations
1
Primary Topic
Pleural and Pulmonary Diseases
Type
article
Field-Weighted Citation Impact
1.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diagnostic value of CEACAM6 and HE4 in pleural fluid for malignant pleural effusion

Haoyu Ruan, Mu Yuan, Li-Yuan Lin, Lixia Zhang et al.
1 citations
Annals of Medicine
Pleural and Pulmonary Diseases
1.52
article

Diagnostic value of CEACAM6 and HE4 in pleural fluid for malignant pleural effusion

Haoyu Ruan, Mu Yuan, Li-Yuan Lin, Lixia Zhang, Shengrui Yang, Jian Xu, Jie Li
article en
1 citations

Abstract

Pleural CEACAM6 and HE4 are promising biomarkers for distinguishing MPE from BPE. Their combination improves diagnostic accuracy, offering a valuable tool for MPE diagnosis, especially in challenging cases with cytology-negative pleural effusion.

Annals of MedicineVol. 57(1)
National Clinical Research (US), Jiangsu Province Hospital (CN), Nanjing Medical University (CN)
National Natural Science Foundation of China
Zero hunger
Openalex Percentile: Top 20%
Pleural and Pulmonary Diseases
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.